Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
clinical trials
fda
4
×
life sciences
national blog main
nonalcoholic steatohepatitis
4
×
san diego blog main
4
×
san diego top stories
boulder/denver blog main
boulder/denver top stories
cancer
cancer immunotherapy
detroit blog main
detroit top stories
indiana blog main
indiana top stories
investing
national
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
abbvie
astrazeneca
biotech ipos
bristol-myers squibb
crispr therapeutics
deals
What
drug
4
×
roundup
annual
attention
bio
biotech
ahead
alzheimer’s
ambien
american
approved
asco
assessed
attendees
brings
camp’s
cancer
cash
chicago
city
clinical
combinations
communities
community’s
companies
company
conference
days
developing
digital
disease
disorders
dyne
dyne’s
epidemic
esmo
europe
expanding
fatty
fda
Language
unset
Current search:
fda
×
drug
×
" san diego blog main "
×
" nonalcoholic steatohepatitis "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More
@xconomy.com
5 years ago
Biotech Roundup: ASCO Ahead, CAMP4’s Cash, Ambien Tweeting & More
